Currently, Dr. Islam is an Associate Professor in the Faculty of Medicine at the University of Ottawa and a full-time staff physician in the division of Anatomic and Surgical Pathology within the Eastern Ontario Regional Laboratory Association (EORLA) and The Ottawa Hospital (TOH) for the past 16 years.
Dr. Islam is also the Chair of the Cytopathology Specialty Committee at the Royal College of Physicians and Surgeons of Canada (RCPSC).
Previously, Dr. Islam served as the Director of the Residency Training Program in Anatomic and Surgical Pathology (2011-2021) and General Pathology (2011-2016) for the Royal College of Physicians and Surgeons of Canada (RCPSC) at the University of Ottawa and as the Director of Cytopathology (2005-2010) and the Deputy Head and Site Chief of division of Anatomic and Surgical Pathology at TOH (2006-2011).
Dr. Islam also served at the Chair of Cytopathology Scientific Committee at the Institute of Quality Management in Healthcare (IQMH) (2017-2020) and as a member of the Professional Advisory Committee at the IQMH under Accreditation Canada (2017-2020). Currently, Dr. Islam is a member of the Pathology Scientific Committee at the IQMH.
Dr. Islam is also a Clinician Investigator at the Ottawa Hospital Research Institute (OHRI) since 2005.
Prior to his arrival in Ottawa in 2004, Dr. Islam was a full-time faculty member in the Fienberg School of Medicine in the Department of Pathology at Northwestern University and a staff physician at the Northwestern Memorial Hospital, Chicago, Illinois.
Dr. Islam is a Fellow of the Royal College of Physicians and Surgeons of Canada (RCPSC) and is certified by the American Board of Medical specialties in Anatomic Pathology with fellowship trainings in Surgical pathology (Breast and Gynecologic Oncologic pathology) and Cytopathology. Dr. Islam also obtained a PhD in Cell and Molecular Biology from the University of Toledo, Ohio, USA (1993-1998).
Through his various commitments over the years, Dr. Islam had multiple opportunities to develop leadership skills. Dr. Islam has a proven track record of engaging teams, balancing multiple organizational priorities and the effective delivery of clinical services, academic and research excellence creating an environment of equity, diversity and inclusion (EDI) in the work space. Through his teaching, academic leadership and research, Dr. Islam has demonstrated national and international impact.
Clinician:
Local level:
Dr. Islam's clinical responsibility as a full-time staff physician, primarily include, but not limited to, is diagnostic oncologic surgical pathology and cytopathology at The Ottawa Hospital, which is a member of the Eastern Ontario Regional Laboratory Association (EORLA) and is affiliated with the University of Ottawa. He was also the Director of Cytopathology at the Ottawa Hospital (2005-2010). This section comprised 10 pathologists, 9 cytotechnologists, and 2 technicians at the time. In that capacity, Dr. Islam expanded the clinical service of the section by providing on-site specimen evaluation for bronchoscopy and Wang biopsy procedures in the Bronchoscopy Suite at the Civic Campus. He was also the Deputy Head and Site-Chief for surgical pathology at the Ottawa Hospital (2006-2011). Dr. Islam had been the Residency Program Director for the Royal College of Physicians and Surgeons of Canada (RCPSC) for Anatomical Pathology at the University of Ottawa for the past 10 years (2011-2021). He is also a Clinician Investigator at the Ottawa Hospital Research Institute (OHRI).
National level:
Dr. Islam played a critical role in developing a diploma program called "Area of Focus Competence (AFC) in Cytopathology" at the Royal College of Physicians and Surgeons of Canada. For his role as a founding member, Dr. Islam was recognized by the Royal College of Physicians and Surgeons of Canada (RCPSC) as an "Architect" of the diploma program. Currently, Dr. Islam serves as the Chair of AFC Cytopathology Specialty Committee at the Royal College of Physicians and Surgeons of Canada (RCPSC). He had also been the Chair of the Cytopathology Scientific Committee at the Institute of Quality Management in Healthcare (IQMH) and was actively involved in developing proficiency testing for cytopathology for all the cytology laboratories in Ontario and in other provinces. In that capacity, Dr. Islam was involved in developing "Best Practice Recommendation Guidelines for Gynecologic and Non-Gynecologic Cytopathology". For his work, Dr. Islam was recognized by the IQMH (https://iqmh.org/Resources/News/Post/1116/Elevating-the-profile-of-IQMH-volunteers-Dr-Shahid-Islam).
Dr. Islam was an external reviewer for the quality improvement document in cytology "Best Practice Recommendation for Standards2Cytology-an initiative by Ontario Medical Association (OMA) and College of Physicians and Surgeons of Ontario (CPSO). He was also an external reviewer for multiple Practice Guidelines in gynecologic and lung cancer for Program in Evidence-Based Care by Cancer Care Ontario (PEBC-CCO). Over the years, Dr. Islam done external and internal reviews of many residency programs for the Royal College of Physicians and Surgeons of Canada (RCPSC) at the University of Ottawa and other universities in the country as chair and member of the review committees. Dr. Islam is also a certified Assessor by the College of Physicians and Surgeons of Ontario (CPSO) and Institute of Quality Management in Healthcare (IQMH) and have done practice and proficiency testing assessments for many physicians and laboratories, respectively.
International level:
Dr. Islam had the pleasure and the opportunity to present his original scientific works in as many as 53 international meetings and conferences; some of which are as follows:
1) Asia Pacific International Academy of Pathology Congress;
2). Annual Scientific Meeting of the American Society of Cytopathology;
3) United States and Canadian Academy of Pathology;
4) American Society of Clinical Pathology (ASCP).
He had the pleasure of being an invited speaker in as many as 40 international meetings and conferences. Recently, Dr. Islam have been recognized by the American Society of Clinical Pathology (ASCP) 40 for his project " Pathology Cancer Clinic; An Innovative Model to Quality Patient Care in Collaboration with Gynecological Oncology Team at The Ottawa Hospital" for making an impact on pathology and laboratory medicine.
Dr. Islam has over 100 scientific publications in peer-reviewed journals in the field of Cytopathology, Surgical Pathology and Molecular Pathology in high-rated peer-reviewed journals as follows:
1) Acta Cytologica,
2) Archives of Pathology and Laboratory Medicine,
3) American Journal of Clinical Pathology,
4) Cancer Cytopathology,
5) Diagnostic Cytopathology,
5) Journal of Cell Biology,
6) Journal of Cellular Biochemistry and
7) Histopathology.
He has authored and co-authored 43 book chapters in an online platform at Pathologyoutlines.com which is the world's most popular pathology website, averaging 40,000 daily user sessions.
He was invited by the International Society of Gynecological Pathologists, as a guest at the International Society of Gynecologic Pathology (ISGyP) LiVE podcast series. The series featured discussions centered on a recent article of mine in GYN pathology on biomarkers in the study of uterine smooth muscle neoplasms.
Earlier in his career, Dr. Islam's clinical and research work was profiled in Science, published by the American Association for the Advancement of Science during the time he was working as a clinical fellow at the University of Texas Medical Centre at Dallas, Dallas, Texas, which is among the top sixteen medical schools for research according to U.S. News and World Report and includes four Nobel Prize winners and 12 members of the National Academy of Sciences.
Dr. Islam has also been an invited reviewer for pee-reviewed journals such as:
1) Archives of Pathology and Laboratory Medicine
2) Clinical Cytometry
3) Canadian Journal of Pathology
4) PSI Grant reviewer
5) Human Pathology
6) Pathology and Laboratory International and
7) PathologyOutlines.com, Inc.
Teacher
Dr. Islam used his academic freedom to take advantage of the many teaching opportunities available at the university and hospital levels. Dr. Islam considered it a privilege to be attached to a medical school, and to have the opportunity to teach.
At the University of Ottawa, at the postgraduate level, as a Residency Program Director for the past 10 years, he devoted much of my time creating an environment for providing an organized educational program with guidance and supervision of the learner, facilitating the leaner's ethical, professional, and personal developments while ensuring safe and appropriate care for patients. As a member of the Specialty Committee for Anatomic Pathology at the Royal College of Physicians and Surgeons of Canada (RCPSC), Dr. Islam was actively involved in creating document suits for Competence by Design (CBD) for residency training and was the Lead for implementing CBD in Anatomical pathology residency training in the department of Pathology and Laboratory Medicine at the University of Ottawa. He had the pleasure to showcase CBD implementation in the Ottawa program in many different national and international venues and peer-reviewed journal publications as follows:
1) Teaching the CanMEDS Roles to Laboratory Medicine Residents: Residents as Teachers and Development of ePortfolios, Canadian Journal of Pathology, Volume 6, Issue 3, Page 80-85;
2) Implementation of Competency by Design (CBD) in Anatomical Pathology Residency Training Program at the University of Ottawa, CBME Program Evaluation Summit, International Conference in Residency Education (ICRE), Ottawa, Ontario, September 23, 2019; and
3) Residents as Teachers; Self-assessment of non-medical CanMEDS roles as part of e-portfolio development, International Conference on Residency Education, October, Ottawa, Ontario, Canada. 2012.
For his work with the residency program and resident teaching, Dr. Islam received Residency Program Excellence Award and Excellence in Resident Teaching Award from the Professional Association of Residents of Ontario (PARO). He also received the University of Ottawa, Dr. M. Orizaga Teaching Award for Excellence in Resident Teaching for the Department of Pathology and Laboratory Medicine.
Under his supervision, Dr. Islam had the pleasure to see thirty residents successfully come through the program and peruse fellowship trainings in their chosen subspecialties. Some of these, residents have joined the department after completion of their fellowship trainings.
As the Director of Cytopathology, he had the privilege of training and mentoring international fellows who are now practicing in their own country holding leadership positions.
At the undergraduate level, Dr. Islam was the Founder of the Pathology Interest Group at the University of Ottawa. To that end, he created a learning strategy over a "Lunch and learn" session to incorporate the medical student core curriculum in didactic lecture format tying in clinical relevance and practice pattern of an anatomic pathologist.
This initiative created an immense interest in the medical students to explore pathology as a career in medicine. For the past fifteen years, he had the pleasure delivering lectures to the medical students at the university and have spent hundreds of contact hours teaching one-on-one.
Dr. Islam had been the Research Coordinator for the residency program and actively supervised fellows and residents in many research projects, which translated into presentations at national, international conferences and meetings, publications in high impact scientific journals and awards for the fellows and residents.
At Northwestern Memorial Hospital, Dr. was responsible for teaching fellows and residents. These teaching sessions included didactic and microscopy sessions. Dr. Islam involved residents and fellows in clinically relevant research projects, which translated into presentations at national international scientific meetings and publications in peer-reviewed scientific journals.
Dr. Islam acquired his skills in teaching mostly through the practice of teaching at the university level as a Teaching Assistant while doing his PhD at the University of Toledo, Ohio, USA, and by reading and reflecting on the teaching evaluations that he received since then. Over the years atill now, Dr. Islam tries to emulate those teachers that he admired, or who taught him the most. Dr. Islam also supplemented this by participating in different workshops for teaching at the University of Toledo and Medical College of Ohio, Northwestern University in Chicago, the University of Ottawa, and at the Royal College of Physicians and Surgeons of Canada (RCPSC).
PUBLICATIONS:
Peer Reviewed Published Manuscripts, Commentaries, Practice Guidelines and Book Chapters
1. Area of focused competence in cytopathology: An empowered version of fellowship training in cytopathology in Canada. Islam et. al. Canadian Journal of Pathology (November 2021), Volume 13, Issue 4, www.cap-acp.org
2. Combination of MCM2 with Ki67 and P16 Immunohistochemistry Can Distinguish Uterine Leiomyosarcomas. Keyhanian, Kianoosh; Lage, Janice M. ; Chernetsova, Elizaveta ; Sekhon, Harman; Eslami; Zohreh, Islam, Shahidul (author of correspondence). International Journal of Gynecological Pathology: (June 05, 2019), Volume Publish Ahead of Print - Issue - https://journals.lww.com/intjgynpathology/Abstract/publishahead/Combination_of_MCM2_With_Ki67_and_p16.99091.aspx
3. IFITM1 Outperforms CD10 in Differentiating Low Grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus. Aurelia Busca, Carlos Parra-Herran, Previn Gulavita, Shahidul Islam (author of correspondence). International Journal of Gynecological Pathology, Volume 37, Issue 4, (July 2018), pp. 372-378(7).
4. Combination of cyclin-D1 and MCM2 immunohistochemistry can reliably distinguish uterine leiomyosarcomas. Keyhanian, Kianoosh; Lage, Janice; Chernetsova, Elizaveta; Eslami, Zohreh; Islam, Shahid (author of correspondence). Canadian Journal of Pathology. 2018 Supplement, Vol. 10, p43-43. 1/2p.
5. Histomorphological Changes in Endometriosis in a Patient Treated with Ulipristal: A Case Report. Justin Batemen and Shahidul Islam (author of correspondence). Pathology - Research and Practice Volume 213, Issue 1, (January 2017), Pages 79-81.
6. Architectural Overlap Between Benign Endocervix and Pattern-A Invasive Endocervical Adenocarcinoma: Are All Pattern-A Tumors Invasive? Greg Douglas, Brooke E Howitt, John Schoolmeester, Lauren Schwartz, Zuzana Kos, Shahidul Islam, Bojana Djordjevic, Carlos Parra-Herran. Pathol Res Pract. (2017 July), 213(7): 799-803.
7. Nuclear Immunohistochemical IKK-Eexpression in Flat Epithelial Atypia (FEA) of the Breast: A Predictor of Ipsilateral ADH, In-Situ or Invasive Malignancy? PA Williams, CE Parra-Herran, Y Ayroud, S Islam, DH Gravel, SJ Robertson, C Pratt, Cancer Research, (February 2015), Volume, 76, Issue 4, Pages 01-11.
8. GATA-3 Expression is not Associated with Complete Pathological Response in Triple Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
J. K. Wasserman, P. A. Williams, S. Islam, S. J. Robertson. Pathology - Research and Practice Volume 212, Issue 6, (June 2016), Pages 539-544.
9. Incidental Endometrial Carcinoma Diagnosed at First Trimester Pregnancy Loss – Case Report and Discussion. L. Saciragic, C. Ball, S. Islam, M. Fung Kee Fung. J Obstet Gynaecol Can. (2014), 36(11): 1010-1013.
10. Three-Dimensional Cell Groups with Disordered Nuclei and Cellular Discohesion (3DDD) are Associated with High Sensitivity and Specificity for Cystoscopic Urine Cytopathological Diagnosis of Low-Grade Urothelial Neoplasia. Mai KT, Ball CG, Kos Z, Belanger EC, Islam S, Sekhon H. Diagn Cytopathol. (2014 Jul), 42(7):555-63. doi: 10.1002/dc.23069. Epub 2013 Nov 23.
11. Teaching the Can MEDS Roles to Laboratory Medicine Residents: Residents as Teachers and Development of ePortfolios. S. Strickland and S. Islam (author of correspondence). Canadian Journal of Pathology, (Fall 2014), Volume 6, Issue 3, Page 80-85.
12. A Historical Step for Advanced Cytopathology Training in Canada.
S. Islam, M. Wier and M. Auger (all authors contributed equally). Cancer Cytopath. (January 2015), Volume 123, Issue 1, Pages 7-9.
13. Nuclear Morphometry in Flat Epithelial Atypia of the Breast as a Predictor of Malignancy: A Digital Image-based Histopathologic Analysis. Williams PA, Djordjevic B, Ayroud Y, Islam S, Gravel D, Robertson SJ, Parra-Herran C. Anal Quant Cytopathol Histpathol. (December 2014), 36(6): 305-13.
14. Frequency of Malignancy at Final Excision in Biopsy-diagnosed Benign Papillary Lesions of the Breast. Petkiewitz, S and Islam, S (author of correspondence). Can J Pathol. (Fall 2013), 5(3): Pages 89-95.
15. Co-expression and Cellular Localization of P16 (INK 4a) and Mib1 (Ki-67) Help in Differentiating High Grade Squamous Intraepithelial Lesions from Immature Squamous Metaplasia of the Uterine Cervix. Amin MS, Senterman M, Islam S (author of correspondence). Can J Pathol, (Winter 2011), Volume 3, Issue 4, Pages 20-27.
16. Breast Cancer 1 (BRCA1) Protein Expression as a Prognostic Marker in Sporadic Epithelial Ovarian Carcinoma: an NCIC CTG OV.16 Correlative Study.
Weberpals JI, Tu D, Squire JA, Amin MS, Islam S, Pelletier LB, O'Brien AM, Hoskins PJ, Eisenhauer EA. Annals of Oncology, Volume 22, Issue 11, (November 2011), Pages 2403–2410, https://doi.org/10.1093/annonc/mdq770
17. Cadherin-catenin Protein Expression Profile in Ovarian Neoplasms. S Amin and S. Islam (author of correspondence). European Journal of Cancer 48(6): 64, (November 2012), DOI: 10.1016/S0959-8049(12 )72010-5.
18. Repression of Cancer Cell Senescence by PKCi. Paget JA, Restall IJ, Daneshmand M, Mersereau JA, Simard M, Parolin DAE, Lavictoire S J, Amin MS, Islam S, Lorimer IAJ. Oncogene. (August 2012) Volume 2(31), Pages 3584-3596.
19. BRCA1 protein levels and PI3KA mutations as predictive biomarkers for response to neoadjuvant chemotherapy in locally advanced breast cancer: An exploratory analysis. Hilton JF, Amin MS, Daneshmand M, Weberpals JI, Lorimer I, Islam S, Mallick R, Kanji F, Hopkins S, Verma S. Oncology Letters, 4(1), 141-145, 2012.
20. Immunocytochemical Study of Urine Cytological Preparations from Secondary Prostatic Adenocarcinoma Involving the Urinary Bladder. K. T. Mai, I. Itrat, S. J. Robertson, E. C. Belanger, J. Veinot and S. Islam (author of correspondence). Diagn Cytopathol. (2008 Oct), 36(10):715-20. doi: 10.1002/dc.20886.
21. Atypical Squamous Cells, Cannot Exclude High Grade Squamous Intraepithelial Lesion, ASC-H: Cytohisto correlation and Diagnostic Pitfalls. G. Mokhtar, N. Dilatour, A. Assiri, M. Gilliat, M. Senterman and S. Islam (author of correspondence). Acta Cytol. (2008 Mar-Apr), 52(2):169-77.
22. Cytologic Features of Benign Solitary Pulmonary Nodules with Radiologic Correlation and Diagnostic Pitfalls: A Report of Six Cases. Shahidul Islam (author of correspondence), NL Delatour Roustan, Shafeeq R Salahdeen, Kien T Mai, Mary Senterman, Ghadeer A Mokhtar. Acta Cytol. (2009), Volume 53, Issue 2, Pages 201-210.
23. Progesterone Receptor in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. K. T. Mai, I. Teo, E. C. Belanger, S. Robertson, E. C. Marginean and S. Islam. Histopathology. (2008 Feb); 52(3): 277-82.
24. Fine Needle Aspiration of Biopsy for Pre-operative work of Pancreatic Cystic Neoplasm: Report of 4 Cases. N. R. Delatour, M. C. Policarpio-Nicolas, H. Yazdi, S. Islam (author of correspondence). Acta Cytol. (Nov-Dec 2007), 51(6):925-33.
25. Reprocessing of Unsatisfactory Thin Prep Specimens Increases Specimen Adequacy and Detection of Significant Abnormal Cervicovaginal Lesions. S. Islam (1st author), A. M. West, H. Saboorian and R. Ashfaq. Cancer Cytopath. (2004 April 25), 102(2): 67-73.
26. Fine Needle Aspiration Cytology of Collecting Duct Carcinoma of the Kidney: Distinctive features and Differential Diagnosis. V. R. Sarode, S. Islam (1st author), D. Wooten, K. Molberg and R. Ashfaq. Acta Cytol. (2004), 48(6): 843-8.
27. Urinary Obstruction in a 78- Year-Old-Woman with A Pelvic Mass (a Case of Brenner Tumor and Literature review). G. Gannon, S. Islam, R. Conley and A. Zaher. Archives of Pathology & Laboratory Medicine: (September 2003), Vol. 127, No. 9, pp. 1225-1226.
28. A 29-Year-Old Male with Intermittent Lower Leg Pain. (A Case of Ewing Sarcoma and Literature Review). S. Islam (1st author), R. Conley and A. Zaher. Archives of Pathology & Laboratory Medicine: (July 2003), Vol. 127, No. 7, pp. e311-e312.
29. A 30-Year-Old-Man with Recurrent Pneumonia (a Case of Lung Sequestration and Literature Review). L. Shope, S. Islam and A. Zaher. Archives of Pathology & Laboratory Medicine: May 2002, Vol. 126, No. 5, pp. 623-624.
30. A 48-Year-Old White Woman with a Nodular Mass in the Right Parotid Gland (a Case of Malignant Lymphoma in Parotid Gland and Literature Review). T. Sheridan, S. Islam, and A. Zaher. Archives of Pathology & Laboratory Medicine: (February 2001), Vol. 125, No. 2, pp. 295-296.
31. Deep Venous Thrombosis in a 21- Year-Old Woman with a Retroperitoneal Mass (a Case of Malignant Peripheral Nerve Sheath Tumor and Literature Review). G. Gelickman, S. Islam, and A. Zaher. Archives of Pathology & Laboratory Medicine: (November 2000), Vol. 124, No. 11, pp. 1728-1730.
32. A Case of Systemic Mastocytosis (Literature Review). Islam, S. (author of correspondence), and Zaher, A. Archives of Pathology & Laboratory Medicine: (April 2000), Vol. 124, No. 4, pp. 645-645.
33. Vimentin Expression in Human Carcinoma Cell: Relationship with Phenotypic Changes and Cadherin Based Cell Adhesion. Islam, S (1st author), Wheelock, M. J., and Johnson, K. R. J. Cell. Biochem, (2000) 78(1): 141-150.
34. N-cadherin Extracellular Repeat 4 Mediates Epithelial to Mesenchymal Transition and Increased Motility. Jae-Kim, Islam, Young J. Kim, Ryan S. Prudoff, Kristin M. Sass, Wheelock, M. J., and Johnson, K. R.
J. Cell Biol. (2000) 151(6): 1193-1206.
35. Expression of N-Cadherin by Human Squamous Carcinoma Cells Induces a Scattered Fibroblastic Phenotype with Disrupted Cell-to-Cell Adhesion. Islam, S (1st author), Carey, T. E., Wolf, G. T., Wheelock, M. J., and Johnson, K. R. J. Cell. Biol. (1996) 135(6) 1643-1654.
Peer reviewed commentaries from the Cytopathology Scientific Committee at the Institute of Quality Management in Healthcare (IQMH) at https://iqmh.org/
(14- peer-reviewed publications)
36. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1401. Z. Ghorab, M. Weir, S. Islam (senior author), S. McRae and D. Kuni
37. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1405. S. Islam (1st author), M. Weir, Z. Ghorab, D. Kuni and S. McRae
38. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO 1409-PP (patterns-of-practice). M. Weir, S. Islam (senior author), Z. Ghorab, D. Kuni and S. McRae
39. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys-CYTO-1501. S. Islam (1st author), M. Weir, Z. Ghorab, E. Ecobichon-Morris and S. McRae
40. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1505. S. Islam (1st author), M. Weir, Z. Ghorab, E. Ecobichon-Morris and S. McRae
41. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1601. Z. Ghorab, M. Weir, S. Islam (senior author), E. Ecobichon-Morris and S. McRae
42. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1605. S. Islam (1st author), M. Weir, Z. Ghorab, E. Ecobichon-Morris and S. McRae
43. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1610-PP (patterns-of-practice). M. Weir, S. Islam (senior author), Z. Ghorab, E. Ecobichon-Morris and S. McRae
44. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1701. S. Islam (1st author), Z. Ghorab, C.Zeman-Pocrnich, S. McRae, E. Ecobichon-Morris
45. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1705. Z. Ghorab, S. Islam (senior author), C.Zeman-Pocrnich, S. McRae, E. Ecobichon-Morris and S. McRae
46. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1801. C. Zeman-Pocrnich, S. Islam (senior author), Z. Ghorab, S. McRae, E. Ecobichon-Morris
47. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1805. Z. Ghorab, S. Islam (senior author), C.Zeman-Pocrnich, E. Ecobichon-Morris and S. McRae
48. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1809-PP (patterns-of-practice). C.Zeman-Pocrnich, S. Islam (senior author), Z. Ghorab, S. McRae, E. Ecobichon-Morris
49. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1901-NG. Z. Ghorab, S. Islam (senior author), C.Zeman-Pocrnich, E. Ecobichon-Morris and S. McRae
50. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-Published PATH-2101 Oversight, Iron, Von Kossa, Congo Red
51. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)- PATH-2103 ER, PR, HER2 IHC, HER2 ISH, E-Cadherin
52. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-PATH-2105 CD117, DOG1, GMS, PAS (Fungal)
53. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)PATH-2106 CD68, CD34, SMA, SMM-H
54. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-PATH-2109 SOX10, S-100, Masson Fontana, Trichrome
55. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-PATH-2202 ER, PR, HER2 IHC, HER2 ISH, Cytokeratin 5/6
56. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-PATH-2205 Synaptophysin, Chromogranin, Oversight, Calcium
57. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-PATH-2206 P16, Vimentin, PAX8, WT1
58. Consensus Practice Recommendation – Gynecologic and Non-Gynecologic Cytology, 2015. S. Islam (1st author), Z. Ghorab, C.Zeman-Pocrnich, S. McRae, E. Ecobichon-Morris
External Expert Review of Practice Guidelines, Program in Evidence-Based Care (PEBC-CCO), Canadian Society of Cytopathology (CSC) and Ontario Medical Association (OMA) and College of Physicians and Surgeons of Ontario (CPSO) (10)
59. Best Practice Recommendation Guidelines for Gynecologic and Non-Gynecologic Cytopathology (Institute of Quality Management in Healthcare, IQMH).
60. Best Practice Recommendation for Standards2Cytology document (an initiative by OMA and CPSO).
61. EBS 26-3Evidence-Based Series 26-3IN REVIEWA Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO)Follow-up and Surveillance of Curatively Treated Lung Cancer Patients.
62. Evidence-Based Series #1-19A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Locoregional Therapy of Locally Advanced Breast Cancer (LABC).
63. Evidence-Based Series #15-12Version 2A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) The Organization of Colposcopy Services in Ontario: Recommended Framework
64. Guideline 4-3 Version 4A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Systemic Therapy for Recurrent Epithelial Ovarian Cancer.
65. Evidence -Based Series #7-13-2v2 Recommendations for Prophylactic Cranial Irradiation and Consolidative Radiation for Patients with Small Cell Lung Cancer: Endorsement: 2019 National Institute for Health and Care Excellence.
66. Evidence-guideline #7-A-2018-2 Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations: ASCO and CCO Joint Clinical Practice Guideline Update.
67. Evidence-Based Guideline # 7-A-2018-3 Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Peer Reviewed Electronic Learning Modules Institute of Quality Management and Healthcare (IQMH) at https://iqmh.org/
68. FNA Neck Mass; 48-Year Old Male. Shahidul Islam, Zeina Ghorab, Michele Weir, Anne Ecobichon-Morris, Susan McRae.
https://iqmh.org/Portals/0/Docs/Services/eLearn_Labs/e-Learn%20LAB%20-%20CYTO%201801.
pdf (January, 2018)
69. Anal Pap 47-Year-Old Male; HIV-Seropositive. Zeina Ghorab, Shahidul Islam, Michele Weir, Susan McRae and Anne Ecobichon-Morris.
https://iqmh.org/Portals/0/Docs/Services/eLearn_Labs/e-Learn%20LAB%20-%20CYTO%201701.
pdf (January, 2017).
70. Pap, Liquid-based 42-Year Old Female. Michele Weir, Zeina Ghorab, Shahidul Islam, Ms. Anne Ecobichon-Morris, Susan McRae.
https://iqmh.org/Portals/0/Docs/Services/eLearn_Labs/e-Learn%20LAB%20-%20CYTO%201705.
pdf (May, 2017)
Book Chapters at https://www.pathologyoutlines.com
Completed chapters as Primary Author (43)
1. Ovary - nontumor - Large solitary luteinized follicular cyst of pregnancy and puerperium - 1 Jun 2012
2. Ovary - nontumor - Massive edema of ovary - 1 Jun 2012
3. Ovary - nontumor - Polycystic ovary disease (PCO) - 1 Jun 2012
4. Ovary - nontumor - Pregnancy luteoma - 1 Jun 2012
5. Ovary - nontumor - Rete ovarii cyst - 1 May 2012
6. Ovary - nontumor - Stromal hyperplasia and hyperthecosis - 1 May 2012
7. Ovary - nontumor - Torsion - 1 May 2012
8. Thyroid gland - Fibromatosis/fasciitis-like variant - 1 Mar 2009
9. Thyroid gland - Autoimmune thyroiditis - 1 Mar 2009
10. Thyroid gland - Bethesda guidelines for cytology: Malignant - 1 Jul 2014
11. Thyroid gland - Clear cell change - 1 Mar 2009
12. Thyroid gland - Diffuse follicular variant - 1 Mar 2009
13. Thyroid gland - Encapsulated follicular variant - 1 Mar 2009
14. Thyroid gland - Focal lymphocytic thyroiditis - 1 Mar 2009
15. Thyroid gland - Frozen section - 1 Mar 2009
16. Thyroid gland - Hashimoto thyroiditis - 1 Mar 2009
17. Thyroid gland - Hashimoto's thyroiditis - Fibrous (fibrosing) variant - 1 Mar 2009
18. Thyroid gland - Histology - 1 Mar 2009
19. Thyroid gland - Infectious thyroiditis - 1 Mar 2009
20. Thyroid gland - Infectious thyroiditis - Tuberculous thyroiditis - 2 Mar 2009
21. Thyroid gland - Insular carcinoma - Poorly differentiated carcinoma with rhabdoid features - 2 Mar 2009
22. Thyroid gland - Lithium thyroiditis - 1 Mar 2009
23. Thyroid gland - Macrofollicular variant - 1 Mar 2009
24. Thyroid gland - Mixed medullary-follicular tumors - 1 Mar 2009
25. Thyroid gland - Palpation thyroiditis - 1 Mar 2009
26. Thyroid gland - Papillary carcinoma - follicular variant - 1 Mar 2009
27. Thyroid gland - papillary carcinoma: cytology - 1 Mar 2009
28. Thyroid gland - Physiology - 1 Mar 2009
29. Thyroid gland - Post-partum thyroiditis - 2 Mar 2009
30. Thyroid gland - Postoperative necrotizing granulomas - 1 Mar 2009
31. Thyroid gland - Radiation thyroiditis (radiation induced changes) - 1 Mar 2009
32. Thyroid gland - Riedel thyroiditis - 1 Mar 2009
33. Thyroid gland - Rosai-Dorfman disease - 1 Mar 2009
34. Thyroid gland - SARS related changes - 1 Mar 2009
35. Thyroid gland - Silent thyroiditis - 1 Mar 2009
36. Thyroid gland - Solid variant - 1 Mar 2009
37. Thyroid gland - Solitary papillary hyperplastic nodule - 1 Mar 2009
38. Thyroid gland - Subacute thyroiditis - 1 Mar 2009
39. Thyroid gland - Suspicious for malignancy - 1 Jun 2014
40. Thyroid gland - Thyroid cancer - General - 1 Mar 2009
41. Thyroid gland - Thyroid cancer in children - 1 Mar 2009
42. Thyroid gland - toxic goiter - 1 Mar 2009
43. Thyroid gland - Warthin-like variant - 1 Mar 2009
